CClinicalTrials.gg
CompletedNCT03276247Updated Sep 8, 2017

Iron Status in Women of Reproductive Age Reproductive Age

An observational study in Iron Metabolism Disorders, sponsored by Victor Gordeuk. Completed at 1 site in United States. Open to female participants aged 25 Years to 44 Years. Per ClinicalTrials.gov, last updated 2017-09-08.

Sponsored by Victor Gordeuk · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
22,042
Ages
25 Years to 44 Years
Sex
Female
01

Study summary

Analyzed iron status, HFE mutations and ethnicity for women in five primary care centers in the United States and Canada using de-identified data from the HEIRS study.

Read the detailed description

HEIRS included a cross-sectional screening study of 101,168 patients, 25 years of age or older, in the primary care setting. Participants were recruited from four centers in the U.S .and one in Canada from February 2001 to February 2003. We will evaluate results for women aged 25-44 years of age who are self-reported as Asian, Black, Hispanic or White. The lower detection limit for the serum ferritin (SF) assay in the HEIRS study was 15 μg/L and therefore the definition of iron deficiency will be SF concentration ≤ 15 μg/L. Elevated SF concentrations, possibly indicative of elevated iron stores, will be classified by two definitions: 1) SF concentration > 300 μg/L and 2) SF >200 μg/L in combination with TSAT >45%. Proportions will be compared by Pearson's chi-square. Logistic regression models will be used to identify independent associations with measures of iron deficiency and elevated iron stores.

02

Conditions studied

  • Iron Metabolism Disorders
03

Who can participate

Ages eligible
25 Years to 44 Years
Sexes eligible
Female
Sampling method
Non-probability sample

Study population

Primary care women included in the HEIRS study.

Inclusion criteria

  1. primary care women included in the HEIRS study with in the age range of this study
  2. Self designation as Asian American, African American, Hispanic American or White.

Exclusion criteria

Exclusion Criteria:

  1. Age >44 years
  2. Self-described ethnicity other in than inclusion criterion 2.
04

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
22,042 participants (actual)
Patient registry
No

Groups and cohorts

  • Asian American non-pregnant

    Women 25 to 44 years of age recruited in a primary care setting and self reported as Asian American and non-pregnant/non-breastfeeding.

    Other: observation

  • African American non-pregnant

    Women 25 to 44 years of age recruited in a primary care setting and self reported as African American and non-pregnant/non-breastfeeding.

    Other: observation

  • Hispanic American non-pregnant

    Women 25 to 44 years of age recruited in a primary care setting and self reported as Hispanic American and non-pregnant/non-breastfeeding.

    Other: observation

  • White non-pregnant

    Women 25 to 44 years of age recruited in a primary care setting and self reported as white and non-pregnant/non-breastfeeding.

    Other: observation

  • Asian American pregnant

    Women 25 to 44 years of age recruited in a primary care setting and self reported as Asian American and pregnant or breastfeeding.

    Other: observation

  • African American pregnant

    Women 25 to 44 years of age recruited in a primary care setting and self reported as African American and pregnant or breastfeeding.

    Other: observation

  • Hispanic American pregnant

    Women 25 to 44 years of age recruited in a primary care setting and self reported as Hispanic American and pregnant or breastfeeding.

    Other: observation

  • White pregnant

    Women 25 to 44 years of age recruited in a primary care setting and self reported as White and pregnant or breastfeeding.

    Other: observation

Interventions

  • Otherobservation

    observation

05

What researchers measure

Primary outcomes

  1. Elevated serum ferritin

    Serum ferritin \>300 ug/L

    Time frame: One measurement was made at the time of recruitment and this is the measurement that will be analyzed.

  2. Elevated serum ferritin and transferrin saturation

    Serum ferritin \>200 ug/L and transferrin saturation \>45%

    Time frame: One measurement was made at the time of recruitment and this is the measurement that will be analyzed.

  3. Iron deficiency

    Serum ferritin \<15ug/L

    Time frame: One measurement was made at the time of recruitment and this is the measurement that will be analyzed.

06

Study locations

1 site
  • University of Illinois at Chicago
    Chicago, Illinois 60612, United States
07

References and documents

Publications

  • Gordeuk VR, Brannon PM. Ethnic and genetic factors of iron status in women of reproductive age. Am J Clin Nutr. 2017 Dec;106(Suppl 6):1594S-1599S. doi: 10.3945/ajcn.117.155853. Epub 2017 Oct 25. PubMed 29070555 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03276247
Lead sponsor
Victor Gordeuk
Collaborators
Weill Medical College of Cornell University
Responsible party
Victor Gordeuk (Professor of Medicine, University of Illinois at Chicago) — Sponsor-investigator
First posted
Sep 8, 2017
Start date
Jan 1, 2016
Primary completion
Aug 1, 2017
Completion
Aug 1, 2017
Last update
Sep 8, 2017

Study contacts

Victor R Gordeuk, MD
principal investigator · University of Illinois at Chicago

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion